Clinical Trial Update: Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating vitamin D3 for reducing recurrence of recurrent urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Recurrent Urinary Tract Infection | Phase 2 | Status: UNKNOWN